SÖZ
ALTI
NEWS
Home
The day in news
This week
Archive
Crisis
About
EN
AZ
sözaltı
news
Finance
Finance
EN
AZ
Novartis Trial Failure Serves as Cautionary Tale for Pharma M&A
wsj.com
08.09.2026 12:47
54 views
Copy link
Save
Pick
Edit
Copy link
WhatsApp
Telegram
X
Reddit
Facebook
LinkedIn
Email
More
Image
Share image
Save
Copy link
Similar stories
1 outlet
Amgen Falls 10% as Novartis Trial Failure Clouds a Cholesterol Drug Class; NVS Stock Drops 14%
finance.yahoo.com
08.09.2026
Related stories
Smart financial advisers are dropping ROI, NAV and QCD for plain English when talking to clients
marketwatch.com · 23.10
It’s been a painful month for hedge funds. To turn it around, they are shorting U.S. stocks.
marketwatch.com · 23.10
Island inflation rate rises to 3%, figures show
bbc.co.uk · 23.10
The stock market is splitting in two. Is that signaling trouble ahead, or just a new set of winners?
marketwatch.com · 23.10
Ukraine says Starlink speeds still throttled
ft.com · 23.10
Austria expels Russian diplomats suspected of espionage
ft.com · 23.10
← Previous
Boston Scientific Won’t Meet Guidance Due to Cyberattack
Next →
Apple's long-rumored foldable becomes reality with the $2,000 iPhone Duo